Subject(s)
Adenocarcinoma/surgery , Cystadenocarcinoma/surgery , Ovarian Neoplasms/surgery , Adenocarcinoma/mortality , Adenocarcinoma/pathology , Cystadenocarcinoma/mortality , Cystadenocarcinoma/pathology , Female , Follow-Up Studies , Humans , Ovarian Neoplasms/mortality , Ovarian Neoplasms/pathology , Ovary/pathologySubject(s)
Abortion, Spontaneous/etiology , Delivery, Obstetric , Polyhydramnios/complications , Adult , Amniotic Fluid/metabolism , Female , Fetal Growth Retardation , Humans , Obstetric Labor, Premature/etiology , Placenta Diseases/etiology , Polyhydramnios/epidemiology , Pregnancy , Pregnancy, Multiple , Prognosis , ProlapseABSTRACT
The Authors evaluate the efficacy of the intravenous infusion of PGF2 alpha in the induction of abortion in the second trimester of pregnancy with live fetus (Italian Law no. 194/1978). Abortion occurred in 3 out of 11 (27.27%) nulliparous patients, and uterine curettage was necessary in 2 cases. The interval between administration of the drug and the beginning of uterine contractions was 31.42 +/- 14.15 minutes (range 10 to 35 minutes), the duration of infusion was 7.55 +/- 3.64 hours (range 7 to 9.15 hours), the interval between initiation of infusion and delivery was 8.10 +/- 2.60 hours (range 7 to 9.45 hours), and the dose administered was 20.23 +/- 3.75 mg (range 15 to 25 mg). Side effects were reported in 10 cases (90.90%), and in 5 cases these effects were caused by interruption of infusion. Abortion occurred in 7 out of 13 pluriparous patients (53.84%), and uterine curettage was necessary in 4 cases. The interval between administration of the drug and the beginning of uterine contractions was 20 +/- 12.24 minutes (range 20 to 45 minutes), the duration of infusion was 8.26 +/- 0.9 hours (range 3.10 to 16 hours), the interval between initiation of infusion and delivery was 8.40 +/- 0.8 hours (range 3.0 to 9.6 hours), and the dose administered was 19.28 +/- 5.34 mg (range 5 to 25 mg). Side effects were reported in 11 cases (84.61%), and in 6 cases these effects were caused by interruption of infusion.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Abortion, Therapeutic/methods , Labor, Induced/methods , Prostaglandins F/therapeutic use , Adolescent , Adult , Dinoprost , Female , Humans , Infusions, Intravenous , Pregnancy , Pregnancy Trimester, Second , Prostaglandins F/administration & dosageSubject(s)
Trophoblastic Neoplasms/pathology , Uterine Neoplasms/pathology , Adolescent , Adult , Female , Humans , Pregnancy , Retrospective StudiesSubject(s)
Emotions , Fetal Monitoring , Pregnancy/psychology , Ultrasonography/psychology , Adolescent , Adult , Educational Status , Female , Humans , Socioeconomic FactorsABSTRACT
The Authors studied the frequency of Cesarean section in relation to deliveries in the last trimester of pregnancy, the frequency of repetitive Cesarean section, age and parity of the patients, indication for cesarean section, week of delivery, and perinatal and maternal morbidity and mortality at the First Clinic of Obstetrics and Gynecology, University of Catania, Catania, Italy, from 1972 to 1974 and from 1983 to 1985. The frequency of Cesarean section has increased from 12.07% (735 cases out 6,086 deliveries) to 16.89% (837 cases out of 4,955 deliveries). There was a decrease in frequency of repetitive Cesarean section from 30.47% (224 cases) to 27.95% (234 cases) and in perinatal mortality rate from 4.35% (32 cases out of 735) to 3.19% (27 cases out of 845 newborn). There were no cases of maternal death, while the most common cause of maternal morbidity was uterine atonia. From 1972 to 1974 mechanical causes were the most frequent indication for Cesarean section (28.16% -207 cases), while from 1983 to 1985 previous hysterotomy (32.73% -274 cases) was the main indications for Cesarean section.
Subject(s)
Cesarean Section/trends , Adult , Female , Fetal Death , Humans , Infant, Newborn , Infant, Premature, Diseases/mortality , Italy , Obstetric Labor Complications/surgery , Pregnancy , Reoperation , RiskABSTRACT
The authors report two cases of adnexal torsion. The first case occurred in a 30-year old patient, while the latter was in a woman after induction of ovulation with FSH-LH and hCG. The patient, who had begun a pregnancy was treated with adnexectomy, and delivered at term a normal baby.
Subject(s)
Adnexal Diseases , Adnexal Diseases/surgery , Adult , Female , Humans , Ovulation Induction , Pregnancy , Pregnancy Complications/surgery , Torsion AbnormalityABSTRACT
Labor was induced via intravenous infusion of 16-phenoxy-prostaglandin-E2-methylsulphonylamide in 13 cases of missed abortion and 19 cases of intrauterine fetal death. In all cases Bishop score was less than 4. Delivery occurred within 24 hours in all cases, with a minimal frequency of side effects (six cases of erythema above the incannulated vein and 1 case of diarrhea). The interval between the beginning of the infusion and delivery was 9.42 minutes. Uterine curettage was performed in 9 cases.
